☆ 4.8 Article

Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model

SCIENCE TRANSLATIONAL MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model

Susan Johnson et al.

Summary: The study showed that the oral vaccine candidate VXA-CoV2-1 provided protection against SARS-CoV-2 in Syrian hamsters, reducing weight loss and lung pathology, and completely eliminating infectious virus 5 days postchallenge. Oral immunization induced antispike immunoglobulin G and neutralizing antibodies, demonstrating neutralizing activity.

JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Lihong Liu et al.

Summary: The B.1.1.529/Omicron variant of SARS-CoV-2, initially detected in southern Africa, has rapidly spread globally and is expected to become dominant due to its enhanced transmissibility in the coming weeks. This variant poses a threat to the efficacy of current COVID-19 vaccines and antibody therapies due to its significant antibody resistance. Even individuals who have received vaccines and booster doses may have reduced neutralizing activity against B.1.1.529.

NATURE (2022)

添加到收藏夹

Article Microbiology

Human influenza virus challenge identifies cellular correlates of protection for oral vaccination

David R. McIlwain et al.

Summary: The study demonstrates that the oral influenza vaccine VXA-A1.1 can protect humans from H1N1 virus challenge, and identifies specific cellular immune responses associated with protection, providing important insights for enhancing influenza vaccine efficacy.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

添加到收藏夹

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity

Kathryn A. Ryan et al.

Summary: The study found that high doses of SARS-CoV-2 in ferrets can cause viral RNA shedding in the upper respiratory tract and lung pathology, while lower doses result in milder pathological symptoms. Ferrets re-challenged after virus shedding ceased are fully protected from acute lung pathology.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Microbiology

K18-hACE2 mice develop respiratory disease resembling severe COVID-19

Claude Kwe Yinda et al.

Summary: The study demonstrates that humanized transgenic mice developed dose-dependent disease when inoculated with SARS-CoV-2, showing upper and lower respiratory tract infection with viral replication also in the brain. The pathological and immunological manifestations observed in these mice resemble human COVID-19, suggesting the model's usefulness in elucidating COVID-19 pathogenesis and testing countermeasures.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Biology

SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters

Prabhuanand Selvaraj et al.

Summary: The study found that SARS-CoV-2 infection induces protective immunity in hamsters, preventing re-exposure and limiting transmission, which may help guide public health policies and vaccine development.

LIFE SCIENCE ALLIANCE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

Matan Levine-Tiefenbrun et al.

Summary: COVID-19 vaccines not only provide protection to individual vaccinees, but may also reduce viral load in breakthrough infections, potentially leading to lower infectiousness and further suppressing virus spread.

NATURE MEDICINE (2021)

添加到收藏夹

Review Immunology

SARS-CoV-2-specific T cells in infection and vaccination

Antonio Bertoletti et al.

Summary: Virus-specific T cells during SARS-CoV-2 infection can play a dual role in either protection or pathogenesis, highlighting the importance of studying the function of these cells for future therapeutic and preventative strategies.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Letter Medicine, General & Internal

Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers

Bettina Lange et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Microbiology

Seroconversion and fever are dose-pependent in a nonhuman primate model of inhalational COVID-19

Paul A. Dabisch et al.

Summary: This study found that the probability of SARS-CoV-2 infection following inhalation is dose-dependent in a nonhuman primate model, with a significant impact on disease presentation. The results emphasize the importance of limiting exposure dose in influencing disease transmission and presentation.

PLOS PATHOGENS (2021)

添加到收藏夹

Review Microbiology

Coronavirus biology and replication: implications for SARS-CoV-2

Philip V'kovski et al.

Summary: This review discusses key aspects of coronavirus biology and their implications for SARS-CoV-2 infections, treatment, and prevention strategies. Understanding virus-host interactions at the molecular level is crucial for developing effective intervention strategies. Summarizing the discoveries of SARS-CoV-2 infection and comparing it with other coronaviruses will support future preparedness and combat strategies.

NATURE REVIEWS MICROBIOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study

David Liebowitz et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Anna Z. Wec et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction

Monir Ejemel et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Review Infectious Diseases

Current and new rotavirus vaccines

Rachel M. Burke et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2019)

添加到收藏夹

Review Immunology

The human antibody response to influenza A virus infection and vaccination

Florian Krammer

NATURE REVIEWS IMMUNOLOGY (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial

Leesun Kim et al.

JCI INSIGHT (2018)

添加到收藏夹

Review Microbiology

Polio vaccination: past, present and future

Ananda S. Bandyopadhyay et al.

FUTURE MICROBIOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus

Tadaki Suzuki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

添加到收藏夹

Article Immunology

Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans

Wendy Peters et al.

VACCINE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Transmission of Aerosolized Seasonal H1N1 Influenza A to Ferrets

Heather MacInnes et al.

PLOS ONE (2011)

添加到收藏夹

Review Immunology

Differentiation and homing of IgA-secreting cells

J. R. Mora et al.

MUCOSAL IMMUNOLOGY (2008)

添加到收藏夹

Article Virology

Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus

Y Asahi-Ozaki et al.

JOURNAL OF MEDICAL VIROLOGY (2004)

添加到收藏夹

Review Immunology

Plasma-cell homing

EJ Kunkel et al.

NATURE REVIEWS IMMUNOLOGY (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.